Prestige Consumer Healthcare (PBH) Price & Analysis

Compare

116 Followers

PBH Stock Chart & Stats

$61.74

-$0.15(-0.20%)

At close: Jan 08 4:00 PM EST

$61.74

-$0.15(-0.20%)

Day’s Range― - ―

52-Week Range$57.25 - $90.04

Previous CloseN/A

Volume57.25K

Average Volume (3M)431.82K

Market Cap

$2.97B

Enterprise Value$4.00B

Total Cash (Recent Filing)$119.11M

Total Debt (Recent Filing)$1.04B

Price to Earnings (P/E)15.3

Beta0.32

Next Earnings

Feb 05, 2026

EPS Estimate

1.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.07

Shares Outstanding48,084,010

10 Day Avg. Volume419,866

30 Day Avg. Volume431,818

Financial Highlights & Ratios

PEG Ratio7.62

Price to Book (P/B)2.33

Price to Sales (P/S)3.76

P/FCF Ratio17.56

Enterprise Value/Market Cap1.35

Enterprise Value/Revenue3.60

Enterprise Value/Gross Profit6.38

Enterprise Value/Ebitda11.20

Forecast

1Y Price Target

$77.75

Price Target Upside25.93% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

EPS Forecast (FY)4.55

Revenue Forecast (FY)$1.11B

Bulls Say, Bears Say

Bulls Say

Earnings PerformanceSales and earnings exceeded expectations due to Clear Eyes supply timing and the timing of certain retailer orders.

Free Cash FlowManagement reiterated strong free cash flow of $245M+ for the fiscal year.

Share RepurchasesPrestige bought back 1.6 million shares for $110 million year-to-date, with cumulative free cash flow generation on track to be about $1 billion over the next four years, it has ample capacity to do more.

Bears Say

North America Sales DeclineNorth America sales were down 3.8% driven by continued eye care constraints.

Organic Sales DeclineOrganic sales declined 3% due to anticipated supply constraints, but this was better than expected given help from the timing of Clear Eyes supply and accelerated e-commerce orders that were above consumption.

Sales WeaknessSales weakness is noted while the company works to get their eye care supply back online.

Prestige Consumer Healthcare News

Prestige Consumer price target lowered to $88 from $100 at Canaccord

Canaccord analyst Susan Anderson lowered the firm’s price target on Prestige Consumer (PBH) to $88 from $100 and...

1M ago

PBH

Prestige Consumer Healthcare Reports Q2 Fiscal 2026 Results

Prestige Consumer Healthcare ( ($PBH) ) has released its Q2 earnings. Here is a breakdown of the information...

1M ago

PBH

Prestige Consumer Healthcare’s Earnings Call Highlights Growth and Challenges

Prestige Consumer Healthcare (($PBH)) has held its Q2 earnings call. Read on for the main highlights of the...

1M ago

PBH

Strong Performance and Positive Outlook: Buy Rating for Prestige Consumer Healthcare

William Blair analyst Jon Andersen has maintained their bullish stance on PBH stock, giving a Buy rating on...

1M ago

PBH

Prestige Consumer narrows FY26 adj EPS view to $4.54-$4.58 from $4.50-$4.58

2026 EPS consensus $4.51. Backs FY25 revenue view $1.100B-$1.115B, consensus $1.1B. “Looking ahead, for the full year, we...

1M ago

PBH

Prestige Consumer Healthcare Reports Q2 Fiscal 2026 Results

An announcement from Prestige Consumer Healthcare ( ($PBH) ) is now available. On November 6, 2025, Prestige Consumer...

1M ago

PBH

Prestige Consumer reports Q2 adjusted EPS $1.07, consensus 97c

Reports Q2 revenue $274.1M, consensus $257.24M. “Our Q2 results surpassed our sales and earnings expectations helped primarily by...

1M ago

PBH

Prestige Consumer Healthcare (PBH) Q2 Earnings Cheat Sheet

Prestige Consumer Healthcare (PBH) is scheduled to report 2nd quarter earnings on 11/06/2025, before the market opens. Regarding...

2M ago

PBH

Prestige Consumer price target lowered to $71 from $75 at Jefferies

Jefferies lowered the firm’s price target on Prestige Consumer (PBH) to $71 from $75 and keeps a Hold...

2M ago

PBH

Prestige Consumer price target lowered to $72 from $82 at Oppenheimer

Oppenheimer analyst Rupesh Parikh lowered the firm’s price target on Prestige Consumer (PBH) to $72 from $82 and...

2M ago

PBH

Prestige Consumer upgraded to Buy from Neutral at Sidoti

Sidoti analyst Anthony Lebiedzinski upgraded Prestige Consumer (PBH) to Buy from Neutral with an $80 price target Published...

3M ago

PBH

Buy Rating for Prestige Consumer Healthcare: Strategic Initiatives and Resilience Drive Growth Potential

Susan Anderson, an analyst from Canaccord Genuity, maintained the Buy rating on Prestige Consumer Healthcare. The associated price...

4M ago

PBH

Prestige Consumer Healthcare’s Cautious Earnings Call Outlook

Prestige Consumer Healthcare (($PBH)) has held its Q1 earnings call. Read on for the main highlights of the...

4M ago

PBH

Prestige Consumer price target lowered to $100 from $105 at Canaccord

Canaccord lowered the firm’s price target on Prestige Consumer (PBH) to $100 from $105 and keeps a Buy...

4M ago

PBH

PBH FAQ

What was Prestige Consumer Healthcare’s price range in the past 12 months?

Prestige Consumer Healthcare lowest stock price was $57.25 and its highest was $90.04 in the past 12 months.

What is Prestige Consumer Healthcare’s market cap?

Prestige Consumer Healthcare’s market cap is $2.97B.

When is Prestige Consumer Healthcare’s upcoming earnings report date?

Prestige Consumer Healthcare’s upcoming earnings report date is Feb 05, 2026 which is in 47 days.

How were Prestige Consumer Healthcare’s earnings last quarter?

Prestige Consumer Healthcare released its earnings results on Nov 06, 2025. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.1.

Is Prestige Consumer Healthcare overvalued?

According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Prestige Consumer Healthcare pay dividends?

Prestige Consumer Healthcare pays a Notavailable dividend of $0.475 which represents an annual dividend yield of N/A. See more information on Prestige Consumer Healthcare dividends here

What is Prestige Consumer Healthcare’s EPS estimate?

Prestige Consumer Healthcare’s EPS estimate is 1.14.

How many shares outstanding does Prestige Consumer Healthcare have?

Prestige Consumer Healthcare has 48,084,010 shares outstanding.

What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?

Prestige Consumer Healthcare reported an EPS of $1.07 in its last earnings report, beating expectations of $0.97. Following the earnings report the stock price went up 2.557%.

Which hedge fund is a major shareholder of Prestige Consumer Healthcare?

Currently, no hedge funds are holding shares in PBH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Prestige Consumer Healthcare Stock Smart Score

Neutral

Fundamentals

Return on Equity

11.29%

Trailing 12-Months

Asset Growth

3.78%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Prestige Consumer Healthcare (PBH) Earnings & Revenues

Historic Earnings Reports

PBH Company Deck

PBH Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted strong growth in e-commerce and effective cost management, along with successful market share expansion in the dental category. However, challenges with Clear Eyes supply constraints and declining revenue due to lower sales in key categories were noted. Investment in marketing and strategic acquisitions are expected to support future growth.View all PBH earnings summaries

PBH Stock 12 Month Forecast

Average Price Target

$77.75

▲(25.93% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","74":"$74","89":"$89","66.5":"$66.5","81.5":"$81.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$88.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$77.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$71.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,66.5,74,81.5,89],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.6,62.70769230769231,64.81538461538462,66.92307692307692,69.03076923076924,71.13846153846154,73.24615384615385,75.35384615384615,77.46153846153847,79.56923076923077,81.67692307692307,83.78461538461539,85.8923076923077,{"y":88,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.6,61.91923076923077,63.23846153846154,64.5576923076923,65.87692307692308,67.19615384615385,68.51538461538462,69.83461538461539,71.15384615384616,72.47307692307692,73.79230769230769,75.11153846153846,76.43076923076923,{"y":77.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.6,61.4,62.2,63,63.800000000000004,64.6,65.4,66.2,67,67.8,68.6,69.4,70.2,{"y":71,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":74.64,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.05,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.99,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.73,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.23,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.49,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.72,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.36,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >